DJ Shipley on ibogaine and PTSD: a compelling case, not a clinical trial
The retired Navy SEAL credits ibogaine with ending his suicidal ideation; the documentary telling his story is testimony, not a clinical trial.
The Statement
Ibogaine saved my marriage, ended my suicidal ideation, and showed me the actual source of my PTSD.
Source: VETS (Veterans Exploring Treatment Solutions) — 'In Waves and War' (documentary release).
Context
Shipley spent almost 17 years with the Navy SEAL Teams (2002-2019). After transitioning out, he developed traumatic brain injury and post-traumatic stress that showed up as depression, anxiety, rage, isolation, and suicidal thoughts. Because ibogaine and 5-MeO-DMT are not approved for medical use in the United States, he traveled to Mexico for treatment through VETS, a nonprofit that funds psychedelic-assisted treatment for veterans and special-operations personnel. He is now featured in "In Waves and War," a 2024 documentary (later distributed on Netflix) about Navy SEALs using ibogaine and 5-MeO-DMT to treat PTSD, and has since accompanied other veterans to Mexico for their first ibogaine experiences, offering peer support from his own experience. The film adds to a growing cluster of public veteran testimony — alongside groups like the Marcus and Morgan Luttrell-linked ibogaine advocacy that helped drive the April 2026 White House executive order fast-tracking FDA review of psychedelic treatments including ibogaine for veterans.
What The Evidence Shows
Shipley's account is consistent with the strongest controlled evidence this site tracks: Stanford's MISTIC trial (Cherian et al., Nature Medicine, 2024) gave magnesium-ibogaine to 30 special-operations veterans with traumatic brain injury and found an 88% reduction in PTSD symptoms with no serious cardiac adverse events. That trial is a genuine signal, but it is 30 people in a single supervised study, not a general-population result, and it used magnesium co-administration specifically to manage ibogaine's well-documented cardiac risk (QT-interval prolongation, which has caused fatal arrhythmias in unsupervised settings). Ibogaine and 5-MeO-DMT remain Schedule I and unapproved for any use in the United States, which is precisely why veterans travel to unregulated clinics in Mexico rather than receiving treatment domestically. See our ibogaine guide for the full safety and legal picture, including current FDA-track clinical trials.
Where It Lands
Ibogaine treatment ended my suicidal ideation and saved my marriage.
Consistent with documented case reports and the Stanford MISTIC trial's aggregate results in a similar veteran population, but an individual testimonial is not a controlled-trial outcome.
Ibogaine and 5-MeO-DMT are approved, medically supervised treatments in the US.
Both remain Schedule I and unapproved for any use in the United States; that legal status is exactly why Shipley and other veterans travel to Mexico for treatment.
The documentary shows psychedelics work for every veteran with PTSD.
Individual cases and one 30-person trial are a real signal, not proof of a general treatment effect; ibogaine also carries a documented cardiac risk that requires medical screening.
Bottom Line
Shipley's story is a serious, well-documented individual case that lines up with real clinical-trial data on ibogaine for veteran PTSD and TBI — that combination is what makes it compelling. It is still one person's account, not proof the treatment works for every veteran, and it does not change the underlying facts: ibogaine carries a real cardiac risk, is not FDA-approved, and is not legally available for this use inside the US. Anyone considering it should read the safety screening requirements before traveling, not just the outcome.
Frequently asked questions
Who is DJ Shipley and why is he connected to ibogaine?
DJ Shipley is a retired U.S. Navy SEAL who served nearly 17 years (2002-2019). After leaving the service he developed traumatic brain injury and PTSD symptoms including suicidal ideation. He traveled to Mexico for ibogaine and 5-MeO-DMT treatment through the veteran nonprofit VETS, and is now featured in the 2024 documentary "In Waves and War."
Is ibogaine treatment for PTSD backed by clinical research, or just Shipley's story?
Both. Shipley's account is a personal testimonial, but it lines up with Stanford's MISTIC trial (Cherian et al., Nature Medicine, 2024), which gave magnesium-ibogaine to 30 special-operations veterans with TBI and found an 88% reduction in PTSD symptoms with no serious cardiac adverse events. That is real controlled evidence in a similar population, though still a small single study rather than proof the treatment works broadly.
Can a veteran get ibogaine treatment for PTSD in the United States?
Not currently as an approved medical treatment. Ibogaine is Schedule I and unapproved for any use in the US, which is why Shipley and other veterans travel to clinics in Mexico. Domestic access is limited to FDA-authorized clinical trials, such as the Stanford MISTIC extension and the Texas IMPACT consortium funded by Senate Bill 2308. See our ibogaine guide for the current list of active US trials.
Editorial commentary. Not medical or legal advice. Not endorsed by or affiliated with DJ Shipley.